Minerva Neurosciences, Inc. appointed Dr. Inderjit Kaul to its Board of Directors on November 14, 2025, increasing the Board to six members and granting him a cash retainer of $40,000 along with equity compensation. This appointment follows a securities purchase agreement with investors to expand the Board.